Communicating Information About Medication: The Benefits of Making it Personal

Berry, Dianne C.; Michas, Irene C.; Bersellini, Elisabetta

doi:10.1080/0887044031000080683

Cited by 28 publications

(34 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…35,[105][106][107][108][109][110][111] The remaining trials, which enrolled members of the general public, used information referring to a scenario for a fictitious medicine. [105][106][107][108][109][110] This set of trials is qualitatively distinct from the other trials included in the review because they examined the effect of a single component of the written information, that is, the description of the risk of a side-effect. The majority of these trials were motivated by EU guidance, which defined verbal descriptors for a series of numerical frequency bands of incidence.…”

Section: Description Of Included Trialsmentioning

confidence: 99%

Section: Description Of Included Trialsmentioning

confidence: 99%

“…35,[105][106][107][108][109][110][111] Two trials enrolled participants who were currently receiving treatment and provided information about a real medicine. 35,[105][106][107][108][109][110][111] The remaining trials, which enrolled members of the general public, used information referring to a scenario for a fictitious medicine. [105][106][107][108][109][110] This set of trials is qualitatively distinct from the other trials included in the review because they examined the effect of a single component of the written information, that is, the description of the risk of a side-effect.…”

Section: Description Of Included Trialsmentioning

confidence: 99%

“…34,78,85,97,99 The source of funding was reported in 16 trials. 79,81,[83][84][85]87,88,[95][96][97]99,100,103,104,106,107 Eleven trials were funded by a national funding body, four were funded by a charitable organisation and two were funded by a pharmaceutical company. One trial received joint funding from both a research council and pharmaceutical company.…”

Section: Effectiveness Review Overviewmentioning

confidence: 99%

See 3 more Smart Citations

A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines

Raynor¹,

Blenkinsopp²,

Knapp³

et al. 2007

Health Technol Assess

256

250

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) programme, now part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the costs, effectiveness and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined to include all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care, rather than settings of care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as ...

show abstract

Section: Description Of Included Trialsmentioning

confidence: 99%

Section: Description Of Included Trialsmentioning

confidence: 99%

Section: Description Of Included Trialsmentioning

confidence: 99%

Section: Effectiveness Review Overviewmentioning

confidence: 99%

See 2 more Smart Citations

A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines

Raynor¹,

Blenkinsopp²,

Knapp³

et al. 2007

Health Technol Assess

256

250

View full text Add to dashboard Cite

show abstract

“…Berry et al [26] showed that a more personalised style was related to greater satisfaction, reinforcing the value of addressing individual spiritual needs. Balint emphasised transference and counter transference, necessitating that clinicians are aware that their behaviour and beliefs may impact on their patients.…”

Section: Implications Of Consultation Modelsmentioning

confidence: 99%

Spiritual Discussion: Relevance, Benefits and Application to Primary Care Consultations

2014

Primary Health Care

View full text Add to dashboard Cite

Attitudes toward disclosure of medication side effects: a nationwide survey of Korean patients, caregivers, and oncologists

et al. 2015

View full text Add to dashboard Cite

Background: We aimed to compare the views of cancer patients, family caregivers, and oncologists about the disclosure of side effects in respect to their probability of occurrence, severity, and treatment purpose. We also compared attitudes toward potential harm of side effect disclosure, patients' perceived ability to understand the risk of the side effects, and informed decision-making regarding side effects.Methods: A national survey was performed with 750 patient-caregiver dyads (75.5% participation rate) recruited by 134 oncologists in 13 cancer centers (93% participation rate). Attitudes toward communication of side effects were assessed in terms of drug purpose, severity of potential complications, and probability of harm.Results: Most patients (82.1-87.0%) and caregivers (75.9-81.5%) thought they should be informed of all possible drug side effects regardless of risk, severity, or drug purpose and wanted these risks to be communicated explicitly. Patients and their caregivers believed that detailed explanations of side effects did not harm patients, and further, they believed that patients could understand risks and make treatment decision based on that information. In contrast, oncologists held less positive attitudes toward providing detailed information about drug side effects, especially if they were not severe and if the drugs were designed for supportive care.Conclusion: Cancer patients and family members had different perspectives and preferences regarding communication of drug side effects from their oncologists. The data from our study can serve as a guide for oncologists in presenting side effects information to their patients, as well as a basis for physician training.

show abstract

Communicating Information About Medication: The Benefits of Making it Personal

Cited by 28 publications

References 20 publications

A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines

A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines

Spiritual Discussion: Relevance, Benefits and Application to Primary Care Consultations

Attitudes toward disclosure of medication side effects: a nationwide survey of Korean patients, caregivers, and oncologists

Contact Info

Product

Resources

About